跳至主要内容
临床试验/JPRN-jRCT2080220515
JPRN-jRCT2080220515未知3 期

A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episode

Otsuka Pharmaceutical Co., Ltd.0 个研究点开始时间: 2008年2月1日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 64age old(—)
性别
All

入选标准

  • Trial subjects will be men and women of age 18 or above and below the age of 65 who will not be turning 65 during the trial.
  • -Subjects who meet DSM-IV-TR criteria for manic or mixed episodes and have been diagnosed as having 296.4x Bipolar I Disorder in which the most recent episode was manic or 296.6x Bipolar I Disorder in which the most recent episode was mixed
  • -Subjects who were enrolled in and have completed or withdrawn from Study 003 and who meet the following criteria
  • Subjects who show exacerbation of condition or no change in condition:
  • Those subjects who completed Study 003, and whose score for CGI-BP Change from preceding phase (mania) on Day 21 (completion of Study 003) was between 5 (Minimally worse) and 7 (Very much worse) (subjects showing exacerbation of condition), or whose score was 4 (No change) (subjects showing no change in condition)
  • Subjects who discontinued due to lack of drug efficacy:
  • Those subjects who discontinued Study 003 between Day 14 and Day 21, for whom the reason of withdrawal was lack of drug efficacy, and whose score for CGI-BP Change from preceding phase (mania) was between 5 (Minimally worse) and 7 (Very much worse)

排除标准

  • 未提供

研究者

相似试验

未知
3 期
A multicenter investigative study of the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episodeAcute manic and mixed episodes associated with Bipolar I Disorder
JPRN-jRCT2080220516Otsuka Pharmaceutical Co., Ltd.
招募中
不适用
Prospective multicenter study regarding the safety of surgical results of laparoscopic pancreatic resection; Japanese Society for Endoscopic Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, and Japan Society for Endoscopic Surgery cooperative studyPancreatobiliary diseases (Patients planned to undergo laparoscopic pancreatic resection)
JPRN-UMIN000022836Japanese Society for Endoscopic Pancreatic Surgery3,000
尚未招募
不适用
A single centre prospective study on the safety and efficacy of per oral endoscopic myotomy (POEM) in the endoscopic management of achalasia and other oesophageal motility disorderAchalasiaEsophageal Motility DisorderOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonSurgery - Surgical techniques
ACTRN12619001011178Royal Adelaide Hospital50
进行中(未招募)
不适用
A multi-center, double-masked study of the safety and efficacy of Travoprost APS compared to TRAVATAN in patients with open-angle glaucoma or ocular hypertension. - Efficacy study of Travoprost APS versus TRAVATA
EUCTR2008-006027-31-LVAlcon Research, Ltd.330
进行中(未招募)
不适用
A multi-center, double-masked study of the safety and efficacy of Travoprost APS compared to TRAVATAN in patients with open-angle glaucoma or ocular hypertension. - Efficacy study of Travoprost APS versus TRAVATAOpen-angle glaucoma or ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertension
EUCTR2008-006027-31-BEAlcon Research, Ltd.330